Muhammed Afolabi (MRC Gambia) received an ASTMH 2015 Annual Meeting Travel Award that is supported in part by the Bill & Melinda Gates Foundation.
PHARVAT is a European Commission (EC) Seventh Framework Programme (FP7) funded project aiming to generate a harmonised procedure to permit pre-clinical selection of vaccine adjuvants. The project is running for a two year period and was initiated in November 2009 with an overall budget of € 300 000.
The WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance is delighted to announce to you its maiden Vaccine Pharmacovigilance Fellowship Programme. Deadline for registration is 21st August 2015. For enquiries kindly contact us at training [at] who-pvafrica [dot] org
EVI congratulates GlaxoSmithKline and PATH Malaria Vaccine Initiative (MVI) on their resounding success on the development of MosquirixTM, also known as RTS,S, for use in children aged six weeks to 17 months.